BioSpace News Archive

Pemazyre received Orphan Drug, Breakthrough Therapy and Priority Review designations based on the significant needs of people living with this devastating cancer

To mark the 30th Anniversary of World Haemophilia Day, Sobi™ have released the 2020 Haemophilia Index which examines the quality of life for people with haemophilia in Europe, and the reach of humanitarian aid across the globe.

UK diagnostics firm Intelligent Fingerprinting – developers of the world’s only portable fingerprint-based drug screening system – believes that the highly sensitive fluorescence measurement capabilities of its lateral flow technology and portable instrumentation could have a valuable role to play in accelerating Coronavirus diagnostic testing at the point of care.

Motus Nova was recognized by the Emory Entrepreneurship Network for leading innovation in technology with its robotic at-home stroke rehab devices

Todos Medical Ltd. (OTCQB: TOMDF), a commercial in vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders as well as point-of-care and lab-based tests for COVID-19, announces the appointment of Lauren Chung, Ph.D. to its Board of Directors.

Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced that the Company will host its fourth quarter and fiscal year 2019 earnings conference call on Friday, April 24, 2020 at 8:00 am Eastern Time (5:00 am Pacific Time/ 8:00 pm Beijing Time) to discuss the Company’s financial results for the fourth quarter and fiscal year ended December 31, 2019.

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the United States Food and Drug Administration (“FDA”) denied the Citizen Petition filed by Clarus Therapeutics Inc. (“Clarus”) on October 2 , 2019. Specifically, the FDA declined to issue

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointments of Matthew Klein , M.D., to Chief Development Officer and Eric Pauwels to Chief Business Officer. Dr. Klein will be responsible for the development of our clinical stage programs. As the Chief Business Officer, Mr. Pauwels will be responsible for our c

Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that a scientific paper describing the use of Cymerus™ mesenchymal stem cells (MSCs) in a model of Acute Respiratory Distress Syndrome (ARDS) has been accepted for publication in the American Journal of Respiratory and Critical Care Medicine (AJRCCM). 1 The AJRCCM, commonly known as “ The Blue Journal

New patient registry is also now available to all hospitals willing to capture meaningful data about their COVID-19 patients